Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours
1996

Bone Morphogenetic Protein Type IB Receptor in Malignant Glioma

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): N Yamada, M Kato, P ten Dijkel, H Yamashita, TK Sampath, C-H Heldin, K Miyazono, K Funa

Primary Institution: Ludwig Institute for Cancer Research

Hypothesis

Do bone morphogenetic protein receptors play a role in the pathogenesis of malignant gliomas?

Conclusion

The study found that BMPR-IB is significantly increased in malignant glioma compared to low-grade astrocytomas and gliosis, suggesting a functional role for BMPs in these tumors.

Supporting Evidence

  • BMPR-IB was significantly increased in malignant glioma compared to low-grade astrocytomas.
  • ActR-I staining was weakly expressed in malignant glioma tumors.
  • OP-1 was expressed in nervous tissue and detected in anaplastic areas of malignant glioma.

Takeaway

This study looked at how certain proteins are found in brain tumors and found that one type of protein is more common in the bad tumors than in the less serious ones.

Methodology

The study used immunohistochemical techniques to analyze tissue specimens from glioma and gliosis cases.

Participant Demographics

The study included 16 cases of human glioma and 5 cases of non-tumorous gliosis tissue.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication